The role of KDM4A‐mediated histone methylation on temozolomide resistance in glioma cells through the HUWE1/ROCK2 axis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of KDM4A‐mediated histone methylation on temozolomide resistance in glioma cells through the HUWE1/ROCK2 axis
Authors
Keywords
-
Journal
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-24
DOI
10.1002/kjm2.12768
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanism of circHIPK3-miRNA-124-3p/miRNA-148b-3p-Mediated Inflammatory Responses and Cell Senescence in <b><i>Candida albicans</i></b>-Induced Septic Acute Kidney Injury
- (2022) Jing Han et al. GERONTOLOGY
- NcRNAs: Multi‑angle participation in the regulation of glioma chemotherapy resistance (Review)
- (2022) Zhaomu Zeng et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The giant E3 ligase HUWE1 is linked to tumorigenesis, spermatogenesis, intellectual disability, and inflammatory diseases
- (2022) Lu Qi et al. Frontiers in Cellular and Infection Microbiology
- The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression
- (2022) Ye Yuan et al. Cancer Communications
- Mechanistic insights into KDM4A driven genomic instability
- (2021) Nicolas L. Young et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- The emerging role of KDM5A in human cancer
- (2021) Guan-Jun Yang et al. Journal of Hematology & Oncology
- Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Gliomas
- (2021) Zheng Zhao et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma
- (2021) Meng Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting KDM4A epigenetically activates tumor-cell-intrinsic immunity by inducing DNA replication stress
- (2021) Wuchang Zhang et al. MOLECULAR CELL
- Unravelling KDM4 histone demethylase inhibitors for cancer therapy
- (2021) Stephin Baby et al. DRUG DISCOVERY TODAY
- Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
- (2021) Manendra Singh Tomar et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC
- (2021) Boya Zhang et al. ONCOGENE
- Targeting ROCK signaling in health, malignant and non-malignant diseases
- (2020) Roya Shahbazi et al. IMMUNOLOGY LETTERS
- The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer
- (2020) Xiaofeng Gong et al. INVESTIGATIONAL NEW DRUGS
- Impact of RhoA overexpression on clinical outcomes in cervical squamous cell carcinoma treated with concurrent chemoradiotherapy
- (2020) Keiichi Tanaka et al. JOURNAL OF RADIATION RESEARCH
- O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy
- (2020) Wei Yu et al. Frontiers in Oncology
- LncRNA MAGI2-AS3 is downregulated in the distant recurrence of hepatocellular carcinoma after surgical resection and affects migration and invasion via ROCK2
- (2020) Gang Fang et al. Annals of Hepatology
- Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration‐resistant prostate cancer
- (2019) Xiaoliang Chen et al. PROSTATE
- CDKL5 promotes proliferation, migration, and chemotherapeutic drug resistance of glioma cells via activation of the PI3K/AKT signaling pathway
- (2019) Zhenfu Jiang et al. FEBS Open Bio
- Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
- (2018) Xin Zhang et al. Cell Death & Disease
- Disulfiram, a Re-positioned Aldehyde Dehydrogenase Inhibitor, Enhances Radiosensitivity of Human Glioblastoma Cells In Vitro
- (2018) Hyeon Kang Koh et al. Cancer Research and Treatment
- Downregulation of KDM4A Suppresses the Survival of Glioma Cells by Promoting Autophagy
- (2016) Bo Wang et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential
- (2015) Yangbo Feng et al. JOURNAL OF MEDICINAL CHEMISTRY
- The epidemiology of glioma in adults: a "state of the science" review
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Downregulation of ROCK2 through Nanocomplex Sensitizes the Cytotoxic Effect of Temozolomide in U251 Glioma Cells
- (2014) Xiaojun Wen et al. PLoS One
- Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas
- (2013) Adam M. Fontebasso et al. ACTA NEUROPATHOLOGICA
- Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis
- (2013) F Peng et al. BRITISH JOURNAL OF CANCER
- A Network of Substrates of the E3 Ubiquitin Ligases MDM2 and HUWE1 Control Apoptosis Independently of p53
- (2013) M. Kurokawa et al. Science Signaling
- Antitumor Activity of NVP-BKM120--A Selective Pan Class I PI3 Kinase Inhibitor Showed Differential Forms of Cell Death Based on p53 Status of Glioma Cells
- (2011) D. Koul et al. CLINICAL CANCER RESEARCH
- Alkylpurine–DNA–N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients
- (2011) Sameer Agnihotri et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma
- (2010) Michael D. Blough et al. JOURNAL OF NEURO-ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More